10.2217/14750708.5.5.623 © 2 Disease-modifying therapies in multiple sclerosis have demonstrated a beneficial effect on disease activity. Furthermore, an increasing number of new therapeutic strategies with a diverse set of actions are becoming available. However, not all patients respond to current disease-modifying therapies, and a substantial interindividual variability exists in both effica...

Available options for Alzheimer's disease are used only for symptomatic improvement, but disease-modifying therapies may help triple annual medication sales by 2023.

Agents are approved to treat exacerbations and symptoms and as disease-modifying therapy. Most therapies in the works would address relapsing forms of the disease.

With disease-modifying treatments available for relapsing-remitting multiple sclerosis (MS), the quest for therapies for progressive MS has become a key focus of research.